Effects of different integrase strand transfer inhibitors on body weight in patients with HIV/AIDS: a network meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of different integrase strand transfer inhibitors on body weight in patients with HIV/AIDS: a network meta-analysis
Authors
Keywords
-
Journal
BMC INFECTIOUS DISEASES
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-03
DOI
10.1186/s12879-022-07091-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy
- (2020) Jordan E Lake et al. CLINICAL INFECTIOUS DISEASES
- Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada
- (2020) Kassem Bourgi et al. Journal of the International AIDS Society
- Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort
- (2019) Annalisa Mondi et al. Journal of the International AIDS Society
- CD4-T cell enumeration in human immunodeficiency virus (HIV)-infected patients: A laboratory performance evaluation of Muse Auto CD4/CD4% system by World Health Organization prequalification of in vitro diagnostics
- (2019) Ann Ceulemans et al. PLoS One
- Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy
- (2019) Kassem Bourgi et al. CLINICAL INFECTIOUS DISEASES
- Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial
- (2019) Hans-Jürgen Stellbrink et al. Lancet HIV
- Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial
- (2019) David A Wohl et al. Lancet HIV
- Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
- (2019) Paul E Sax et al. CLINICAL INFECTIOUS DISEASES
- Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir
- (2019) Leonardo Calza et al. INFECTION
- Weight gain and integrase inhibitors
- (2019) Allison Ross Eckard et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Malignant melanoma in HIV: Epidemiology, pathogenesis, and management
- (2019) Alessio Facciolà et al. Dermatologic Therapy
- Adipocytes impair efficacy of antiretroviral therapy
- (2018) Jacob Couturier et al. ANTIVIRAL RESEARCH
- Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors
- (2018) David R Bakal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy
- (2018) Vanessa El Kamari et al. CLINICAL INFECTIOUS DISEASES
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- (2018) Michael S. Saag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
- (2017) Joel Gallant et al. LANCET
- Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada
- (2016) John R. Koethe et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines
- (2016) Ricardo Moure et al. ANTIVIRAL RESEARCH
- Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s
- (2016) Grace A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals
- (2016) Melissa Herrin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Weight Change After Antiretroviral Therapy and Mortality
- (2015) B. Yuh et al. CLINICAL INFECTIOUS DISEASES
- Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation
- (2015) Fred R. Sattler et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Resistance to HIV Integrase Strand Transfer Inhibitors Among Clinical Specimens in the United States, 2009–2012
- (2013) Christopher B. Hurt et al. CLINICAL INFECTIOUS DISEASES
- A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection
- (2013) Jürgen K. Rockstroh et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
- (2013) Francois Raffi et al. LANCET
- Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
- (2013) Thibault Mesplède et al. Retrovirology
- Short Communication: From Wasting to Obesity: Initial Antiretroviral Therapy and Weight Gain in HIV-Infected Persons
- (2012) Wanda Lakey et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- HIV infection and obesity: where did all the wasting go?
- (2012) Tyler Tate et al. ANTIVIRAL THERAPY
- Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia
- (2010) John R Koethe et al. AIDS
- Association Between Weight Gain and Clinical Outcomes Among Malnourished Adults Initiating Antiretroviral Therapy in Lusaka, Zambia
- (2010) John R Koethe et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Increasing Rates of Obesity among HIV-Infected Persons during the HIV Epidemic
- (2010) Nancy Crum-Cianflone et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started